title: Indifferently pursued or unowned drugs: who should lead where companies do not tread?
authors.forename: Edward A
authors.initials: EA
authors.lastname: Sausville
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004345:Drug Industry; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009965:Orphan Drug Production; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019311:Staurosporine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; C054852:7-hydroxystaurosporine; D019311:Staurosporine